CN101862419A - Externally applied medicament for treating closed bone injuries - Google Patents
Externally applied medicament for treating closed bone injuries Download PDFInfo
- Publication number
- CN101862419A CN101862419A CN200910022323A CN200910022323A CN101862419A CN 101862419 A CN101862419 A CN 101862419A CN 200910022323 A CN200910022323 A CN 200910022323A CN 200910022323 A CN200910022323 A CN 200910022323A CN 101862419 A CN101862419 A CN 101862419A
- Authority
- CN
- China
- Prior art keywords
- radix
- externally applied
- injuries
- medicine
- bone injuries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an externally applied medicament for treating closed bone injuries. The externally applied medicament is characterized by consisting of the following raw materials by weight: 5 to 20g of Himalayan teasel root, 5 to 20g of fortune's drynaria rhizome, 5 to 20g of acanthopanax bark, 5 to 13g of notoginseng root, 5 to 13g of rhubarb, 3 to 9g of cassia twig, 3 to 6g of safflower, 3 to 6g of dragon's blood, 3 to 6g of frankincense, 3 to 6g of myrrh, 0.5 to 1g of borneol, and 0.05 to 0.2g of musk. The externally applied medicament has the effects of reducing swelling, alleviating pains, activating blood circulation, dissipating blood stasis, promoting bone marrow to produce platelet, dilating blood vessels, activating blood circulation, quickening callus healing and restoring bone tissues. Proved by hundreds of cases of clinical treatment practice for years, the externally applied medicament has a perfect effect of treating closed bone injuries such as various sprain, fracture, spinal injury and the like; and a treatment course for a patient suffered from minor injuries usually is only about twenty day, the treatment course for a patient suffered from serious injuries is only about forty days, and the cure rate reaches over 95 percent.
Description
Technical field
The invention belongs to Chinese medicine, be specifically related to be a kind of be the medicine for external use of the treatment closed bone injuries of feedstock production with Chinese medicine.
Background technology
Present set a broken bone adopts the method for planter cast or plintlet external fixation usually for general closed bone injuries, is by the open operation back internal fixation that resets for serious closed bone injuries common method, treats to operate on behind the bone injury healing taking-up inner fixed support again.Though this method is effective, patient not only will stand the misery of two operations, and restored cycle is longer, needs usually more than 200 days.In addition, the medical expense height, the conditional request strictness, operation wound is big, stays sequela more.
Although the Chinese medicine medicine for external use of some set a broken bones is arranged at present on the market, they mainly are at some very not serious closed bone injuries, and for serious closed bone injuries, they are helpless basically.
Summary of the invention
The object of the present invention is to provide a kind of medicine for external use that can have good curative effect, do not need both to have alleviated patient's misery by operative treatment to serious closed bone injuries, again can quickly-healing.
Medicine of the present invention is the medicament of being made by the following weight proportion raw material:
Radix Dipsaci 5-20, Rhizoma Drynariae 5-20, Cortex Acanthopancis 5-20, Radix Notoginseng 5-13, Radix Et Rhizoma Rhei 5-13, Ramulus Cinnamomi 3-9, Flos Carthami 3-6, Sanguis Draxonis 3-6, Olibanum 3-6, Myrrha 3-6, Borneolum Syntheticum 0.5-1, Moschus 0.05-0.2.
The optimum weight proportioning of medicine of the present invention is:
Radix Dipsaci 12, Rhizoma Drynariae 12, Cortex Acanthopancis 12, Radix Notoginseng 9, Radix Et Rhizoma Rhei 8, Ramulus Cinnamomi 7, Flos Carthami 5, Sanguis Draxonis 5, Olibanum 5, Myrrha 5, Borneolum Syntheticum 0.8, Moschus 0.1.
The compound method of medicine for external use of the present invention is above-mentioned all medicines to be ground into to mix to mix well behind the fine powder respectively to get final product.
Above-mentioned external prescription is separated:
Monarch drug: Radix Dipsaci, Rhizoma Drynariae, Cortex Acanthopancis, bone and muscle strengthening, continuous folding are hindered, and cure mainly all traumatic injury, the tendon breaking fracture.
Ministerial drug: Radix Notoginseng, Radix Et Rhizoma Rhei, blood stasis is not stayed in hemostasis, and reducing swelling and alleviating pain helps principal agent to control traumatic injury.
Adjuvant drug: Ramulus Cinnamomi, Flos Carthami, Sanguis Draxonis, Olibanum, Myrrha, blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia helps principal agent to control traumatic injury.
Messenger drug: Borneolum Syntheticum, Moschus, understand things pain-stopping.
The medicine for external use that the present invention treats closed bone injuries has the effect of reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, promotion bone marrow manufacturing platelet, blood vessel dilating, quickening blood circulation, callus healing acceleration, reparation osseous tissue.Prove through hundreds of routine clinical practice for many years, this medicine for variously sprain, the curative effect of closed bone injuries such as fracture, spinal injury is very good, generally have only about 20 days light the wounded's the course of treatment, heavy the wounded (recovery from illness standard: of also just about 40 days, can fully recovering through the x-ray fluoroscopy inspection, the healing of fracture callus is good), cure rate is more than 95%.
The using method of this medicine: get an amount of mixed powder and Ovum Gallus domesticus album or vaseline furnishing pasty state, even being spread out on the hospital gauze spreads on the injury, bandaging.If chance displacement fracture, first horizontal reset, the back drug of topical application, wrapping, and can be aided with the clamping plate external fixation.Changed dressings once in 48 hours.
Case 1: Hanzhong City Zhang, the woman, 36 years old, the cadre, on April 10th, 2006 went to a doctor, and left foot habituation is sprained before 2 years, and this medicine of application was fully recovered after two weeks, and left foot did not take place to sprain again over 2 years.
Case 2: the Hanzhong City beam, the man, 21 years old, the workman, right upper extremity swelled and ache JIUYUE in 2007 because of wound causes right hand radius hypomere fracture on 16th.This medicine of application is after one week, the right upper extremity disappearance of swelling and ache, two week the back X-rays show continuous callus formation, after one month, recovery from illness.
Case 3: Hanzhong City Wu, the man, 46 years old, the peasant, on October 26th, 2006, waist 4 waists 5 sacrums 1 compression fracture, waist swells and ache, and can not stand.The disappearance of swelling and ache of ten days back lumbar parts of this medicine of application, the walking of can standing after 20 days, X-ray shows continuous callus formation, recovery from illness after 40 days.
Case 4: Hanzhong City Lee, the man, 58 years old, the peasant, on March 12nd, 2005 went to a doctor, left side external malleolus, internal malleolus double fracture.Before this in local hospitalize 1 year, swell and ache always, X-ray shows not healing of fracture line, disappearances of swelling and ache after 20 days of this medicine of application, the walking of can standing after 30 days, X-ray shows continuous callus formation, fully recovers after 45 days.
The specific embodiment
Embodiment 1:
Take by weighing raw material (gram) according to following proportioning:
Radix Dipsaci 12, Rhizoma Drynariae 12, Cortex Acanthopancis 12, Radix Notoginseng 9, Radix Et Rhizoma Rhei 8, Ramulus Cinnamomi 7, Flos Carthami 5, Sanguis Draxonis 5, Olibanum 5, Myrrha 5, Borneolum Syntheticum 0.8, Moschus 0.1.
Described all medicines are ground into respectively to mix to mix well behind the fine powder get final product.
Embodiment 2:
Take by weighing raw material (gram) according to following proportioning:
Radix Dipsaci 10, Rhizoma Drynariae 10, Cortex Acanthopancis 10, Radix Notoginseng 8, Radix Et Rhizoma Rhei 7, Ramulus Cinnamomi 6, Flos Carthami 5, Sanguis Draxonis 5, Olibanum 5, Myrrha 5, Borneolum Syntheticum 0.8, Moschus 0.1.
Described all medicines are ground into respectively to mix to mix well behind the fine powder get final product.
Embodiment 3:
Take by weighing raw material (gram) according to following proportioning:
Radix Dipsaci 20, Rhizoma Drynariae 20, Cortex Acanthopancis 20, Radix Notoginseng 13, Radix Et Rhizoma Rhei 12, Ramulus Cinnamomi 8, Flos Carthami 6, Sanguis Draxonis 5, Olibanum 5, Myrrha 5, Borneolum Syntheticum 1, Moschus 0.2.
Described all medicines are ground into respectively to mix to mix well behind the fine powder get final product.
Embodiment 4:
Take by weighing raw material (gram) according to following proportioning:
Radix Dipsaci 6, Rhizoma Drynariae 6, Cortex Acanthopancis 6, Radix Notoginseng 5, Radix Et Rhizoma Rhei 5, Ramulus Cinnamomi 4, Flos Carthami 3, Sanguis Draxonis 3, Olibanum 3, Myrrha 3, Borneolum Syntheticum 0.5, Moschus 0.05.
Described all medicines are ground into respectively to mix to mix well behind the fine powder get final product.
Claims (5)
1. a medicine for external use for the treatment of closed bone injuries is characterized in that, presses column weight amount proportion raw material and forms:
Radix Dipsaci 5-20, Rhizoma Drynariae 5-20, Cortex Acanthopancis 5-20, Radix Notoginseng 5-13, Radix Et Rhizoma Rhei 5-13, Ramulus Cinnamomi 3-9, Flos Carthami 3-6, Sanguis Draxonis 3-6, Olibanum 3-6, Myrrha 3-6, Borneolum Syntheticum 0.5-1, Moschus 0.05-0.2.
2. according to the medicine for external use of the described treatment closed bone injuries of claim 1, it is characterized in that, press column weight amount proportion raw material and form:
Radix Dipsaci 12, Rhizoma Drynariae 12, Cortex Acanthopancis 12, Radix Notoginseng 9, Radix Et Rhizoma Rhei 8, Ramulus Cinnamomi 7, Flos Carthami 5, Sanguis Draxonis 5, Olibanum 5, Myrrha 5, Borneolum Syntheticum 0.8, Moschus 0.1.
3. according to the medicine for external use of the described treatment closed bone injuries of claim 1, it is characterized in that, press column weight amount proportion raw material and form:
Radix Dipsaci 10, Rhizoma Drynariae 10, Cortex Acanthopancis 10, Radix Notoginseng 8, Radix Et Rhizoma Rhei 7, Ramulus Cinnamomi 6, Flos Carthami 5, Sanguis Draxonis 5, Olibanum 5, Myrrha 5, Borneolum Syntheticum 0.8, Moschus 0.1.
4. according to the medicine for external use of the described treatment closed bone injuries of claim 1, it is characterized in that, press column weight amount proportion raw material and form:
Radix Dipsaci 20, Rhizoma Drynariae 20, Cortex Acanthopancis 20, Radix Notoginseng 13, Radix Et Rhizoma Rhei 12, Ramulus Cinnamomi 8, Flos Carthami 6, Sanguis Draxonis 5, Olibanum 5, Myrrha 5, Borneolum Syntheticum 1, Moschus 0.2.
5. according to the medicine for external use of the described treatment closed bone injuries of claim 1, it is characterized in that, press column weight amount proportion raw material and form:
Radix Dipsaci 6, Rhizoma Drynariae 6, Cortex Acanthopancis 6, Radix Notoginseng 5, Radix Et Rhizoma Rhei 5, Ramulus Cinnamomi 4, Flos Carthami 3, Sanguis Draxonis 3, Olibanum 3, Myrrha 3, Borneolum Syntheticum 0.5, Moschus 0.05.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910022323XA CN101862419B (en) | 2009-04-20 | 2009-04-20 | Externally applied medicament for treating closed bone injuries |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910022323XA CN101862419B (en) | 2009-04-20 | 2009-04-20 | Externally applied medicament for treating closed bone injuries |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101862419A true CN101862419A (en) | 2010-10-20 |
| CN101862419B CN101862419B (en) | 2011-07-27 |
Family
ID=42954477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910022323XA Expired - Fee Related CN101862419B (en) | 2009-04-20 | 2009-04-20 | Externally applied medicament for treating closed bone injuries |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101862419B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102188527A (en) * | 2011-04-22 | 2011-09-21 | 李何庭 | Chinese medicinal skin externally-stuck bone setting medicament |
| CN104027394A (en) * | 2014-06-17 | 2014-09-10 | 李柳强 | Traditional Chinese medicine preparation for treating fracture and traumatic injury |
| CN104825988A (en) * | 2015-03-28 | 2015-08-12 | 繁昌县智融中药材专业合作社 | Ankle sprain treatment external use traditional Chinese medicine |
| CN105125794A (en) * | 2015-09-06 | 2015-12-09 | 青岛大学 | Pure traditional Chinese medicinal cream for treating closed injury caused by acute physical exercise and preparation method of pure traditional Chinese medicinal cream |
| CN105456605A (en) * | 2016-01-07 | 2016-04-06 | 新疆维吾尔自治区中医医院 | Traditional Chinese medicine for treating bone fracture and preparing method thereof |
| CN110812467A (en) * | 2019-12-12 | 2020-02-21 | 河南中医药大学 | External pine and cinnamon essential oil for promoting fracture rehabilitation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1454660A (en) * | 2003-05-27 | 2003-11-12 | 单凤柱 | Bone-setting medicine |
| CN100339102C (en) * | 2004-01-02 | 2007-09-26 | 陈子旺 | Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation |
| CN101161273B (en) * | 2007-09-21 | 2010-06-23 | 雷广福 | A Chinese patent medicine for treating catagmat |
-
2009
- 2009-04-20 CN CN200910022323XA patent/CN101862419B/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102188527A (en) * | 2011-04-22 | 2011-09-21 | 李何庭 | Chinese medicinal skin externally-stuck bone setting medicament |
| CN102188527B (en) * | 2011-04-22 | 2013-03-06 | 李何庭 | Chinese medicinal skin externally-stuck bone setting medicament |
| CN104027394A (en) * | 2014-06-17 | 2014-09-10 | 李柳强 | Traditional Chinese medicine preparation for treating fracture and traumatic injury |
| CN104825988A (en) * | 2015-03-28 | 2015-08-12 | 繁昌县智融中药材专业合作社 | Ankle sprain treatment external use traditional Chinese medicine |
| CN105125794A (en) * | 2015-09-06 | 2015-12-09 | 青岛大学 | Pure traditional Chinese medicinal cream for treating closed injury caused by acute physical exercise and preparation method of pure traditional Chinese medicinal cream |
| CN105456605A (en) * | 2016-01-07 | 2016-04-06 | 新疆维吾尔自治区中医医院 | Traditional Chinese medicine for treating bone fracture and preparing method thereof |
| CN110812467A (en) * | 2019-12-12 | 2020-02-21 | 河南中医药大学 | External pine and cinnamon essential oil for promoting fracture rehabilitation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101862419B (en) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101862419B (en) | Externally applied medicament for treating closed bone injuries | |
| CN101703757B (en) | Plaster for reuniting fractured tendons and bones and activating blood, and preparation method thereof | |
| CN101703621B (en) | Chinese medicinal plaster for treating hyperosteogeny | |
| CN101637549B (en) | Medicine for treating fracture | |
| CN103285117B (en) | Traditional Chinese medicinal combination for treating bone breakage, bone fracture and hairline fracture | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN101322786B (en) | External-use medicament for treating bone fracture and traumatic injury | |
| CN102872283A (en) | Traditional Chinese medicine composition for treating bone fracture | |
| CN101934011A (en) | Orally taken and externally applied traditional Chinese bone setting medicine | |
| CN100411661C (en) | Amber bolus | |
| CN114209764B (en) | Pharmaceutical composition, preparation and application for treating fracture | |
| CN103156992A (en) | An external application plaster combination for treatment of fracture injuries and a preparation method thereof | |
| CN100562336C (en) | HUOXUEDAN and preparation method thereof | |
| CN102028835B (en) | Chinese medicinal composition for treating fracture | |
| CN100522215C (en) | Traditional Chinese medicine composition for treating traumatic injury and bone fracture | |
| CN103006992A (en) | External medicinal liquor for relieving swelling and pain and preparation method thereof | |
| CN101474331A (en) | Chinese medicine plaster for dispersing swelling | |
| CN102846738A (en) | Paste for rheumatism, traumatic injury and ostealgia | |
| CN103417944A (en) | Swelling diminishing, blood activating and fracture healing ointment and method for manufacturing same | |
| CN101214346B (en) | Chinese medicine emplastrum for treating pain of vertebrae cervicables lumbar intervertebral disc | |
| CN1210055C (en) | Moschus safflower capsules for activating blood and generating bone | |
| Yuan | Assessment of the safety and efficacy of the Chinese herbal formula (CHF) in fracture treatment | |
| CN1176676C (en) | Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process | |
| CN105213640A (en) | A kind of medicine for the treatment of fracture and preparation method thereof | |
| CN1623588A (en) | Chinese medicinal composition for treating bone fracture and soft tissue injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110727 Termination date: 20150420 |
|
| EXPY | Termination of patent right or utility model |